NATCO Pharma Limited (NSEI: NATCOPHARM)
Health Care · Pharmaceuticals · IN
Rs821.30
-2.14% today · -0.2% 1Y
NATCO Pharma Limited (NSEI: NATCOPHARM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.53B and employs 4,433 people.
Over the last twelve months the share price has lost 0.2%, trading between 792.05 and 1.23K.
Tweenvest scores NATCO Pharma Limited across four factors: quality 75/100, value 49/100, growth 82/100, dividend 25/100. Its strongest factor is growth.
NATCOPHARM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.53B
- Revenue (TTM)
- $368.54M
- P/E
- 12.85
- EPS
- 63.89
- Dividend yield
- 0.61%
- Beta (5Y)
- 0.15
- 52-week high
- Rs1,226.80
- 52-week low
- Rs792.05
- Avg volume (3M)
- —
- Shares outstanding
- 179.11M
- Employees
- 4,433
- Next earnings
- —
About NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
- ISIN
- INE987B01026
- Founded
- 1981
- Listed since
- Jan 1, 1996
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rapport Therapeutics, Inc.NasdaqGM: RAPP | $1.54B | $29.85 | -7.21% |
| ANI Pharmaceuticals, Inc.NasdaqGM: ANIP | $1.54B | $71.98 | +0.07% |
| Marksans Pharma LimitedNSEI: MARKSANS | $1.53B | Rs325.60 | -3.37% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.53B | $37.40 | -0.85% |
| Innoviva, Inc.NasdaqGS: INVA | $1.52B | $20.87 | -0.90% |
| Concord Biotech LimitedNSEI: CONCORDBIO | $1.49B | Rs1,374.10 | -5.47% |
| Lotus Pharmaceutical Co., Ltd.TWSE: 1795 | $1.49B | NT$176.00 | +0.28% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.49B | $40.80 | -6.38% |
Figures last refreshed Oct 4, 2026.